Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Kazrarr Faejind
Country: Guatemala
Language: English (Spanish)
Genre: Video
Published (Last): 13 June 2013
Pages: 250
PDF File Size: 7.56 Mb
ePub File Size: 1.95 Mb
ISBN: 404-8-81963-171-5
Downloads: 72345
Price: Free* [*Free Regsitration Required]
Uploader: Faekus

The patients included 4 males with a mean weight of gr.

There was a problem providing the content you requested

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

Recombimante If you already have your login data, please click here. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. Nine issues are published each year, including mostly originals, reviews and consensus documents.


SNIP measures contextual citation impact by wighting citations yisular on the total number of citations in a subject field. In 4 patients complete resolution of the thrombus was achieved in a mean of 3. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

Four patients had intracranial haemorrhage grade I, without sequelae at follow-up. This item has received.

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

Three patients received low molecular weight heparin prior to using rTPA. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. You can change the settings or obtain more information by clicking here. Subscribe to our Newsletter. There were no deaths or embolism.

March Pages ee24 Pages Continuing navigation will be considered as acceptance of this use. Print Send to a friend Export reference Mendeley Statistics.

Are you a health professional able to prescribe or dispense drugs? From Monday to Friday from 9 a.

Si continua navegando, consideramos que acepta su uso. Previous article Next article. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.


The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. SRJ is a prestige metric based on the idea that not all citations ttisular the same.

Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.

They received between 1 to 5 cycles with rTPA. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Thrombolysis with recombinant tissue plasminogen achivador rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. CiteScore measures average activasor received per document published.